Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 25, 2020 - Issue 1
Submit an article Journal homepage
1,713
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist

William A. E. ParkerCardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK;South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UKORCID Iconhttps://orcid.org/0000-0002-7822-8852View further author information
ORCID Icon &
Robert F. StoreyCardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK;South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UKCorrespondence[email protected]
View further author information
Pages 1-6 | Received 06 Dec 2019, Accepted 10 Feb 2020, Published online: 17 Feb 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Steven G. Chrysant & George S. Chrysant. (2020) New and emerging cardiovascular and antihypertensive drugs. Expert Opinion on Drug Safety 19:10, pages 1315-1327.
Read now
Rocco P. Milluzzo, Gabriele A. Franchina, Davide Capodanno & Dominick J. Angiolillo. (2020) Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development. Expert Opinion on Investigational Drugs 29:6, pages 537-546.
Read now

Articles from other publishers (5)

William A. E. Parker & Robert F. Storey. (2023) The role of platelet P2Y 12 receptors in inflammation . British Journal of Pharmacology.
Crossref
Robert F. Storey & William A.E. Parker. (2023) Thrombotic Coronary Occlusion and Reperfusion. Journal of the American College of Cardiology 81:19, pages 1933-1936.
Crossref
Sem A. O. F. Rikken, Robert F. Storey, Felicita Andreotti, Peter Clemmensen & Jurriën M. ten Berg. (2022) Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions. Thrombosis and Haemostasis 123:02, pages 150-158.
Crossref
Raphael Schneider & Jiwon Oh. (2022) Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis. Current Neurology and Neuroscience Reports 22:11, pages 721-734.
Crossref
Bastiaan Zwart, William A. E. Parker & Robert F. Storey. (2020) New Antithrombotic Drugs in Acute Coronary Syndrome. Journal of Clinical Medicine 9:7, pages 2059.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.